Home›Stock Screener›Hemadri Cements

Hemadri Cements Share Price Today | Stock Price & Hemadri Cements Share Screener

HEMACEM Cement
Live Share Price BSE
₹50.88
▲ 1.30 (2.62%)
2025-11-21 00:00:00

As of November 21, 2025, the live Hemadri Cements share price (BSE: HEMACEM) is ₹50.88, up 2.62% from the previous close, with shares trading between ₹48.00 and ₹51.60 in today's trading session, and a 52-week range of ₹49.15–₹55.85. Check Hemadri Cements yearly highs lows for the annual price range and momentum. Use the Hemadri Cements stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Hemadri Cements opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1 and net income of ₹-19, with EBITDA of ₹-10.

Hemadri Cements Market Cap ₹33.10 Cr.
HEMACEM P/E Ratio (TTM) -1.79
Hemadri Cements P/B Ratio -3.90
EPS (TTM) ₹-40.57
Dividend Yield -
Debt to Equity 0.40
HEMACEM 52 Week High ₹55.85
Hemadri Cements 52 Week Low ₹49.15
Operating Margin -
Profit Margin -1900.00%
HEMACEM Revenue (TTM) ₹1.00
EBITDA ₹-10.00
Net Income ₹-19.00
Total Assets ₹24.00
Total Equity ₹-4.00

Hemadri Cements Share Price Chart

Track the current stock price of Hemadri Cements with an interactive chart. Analyse HEMACEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Hemadri Cements stock quote in one place.

The quote of ₹50.88 sits between the 52-week low of ₹49.15 and the 52-week high of ₹55.85, and the latest session moved 2.62% from the previous close.

Hemadri Cements Company Profile - Fundamental Screener

Screen Hemadri Cements company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HEMACEM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Construction sector and the Cement industry, and it trades under ISIN INE07BK01011.

Company Details

Classification

Sector Construction
Industry Cement
Sub-Sector Cement
Segment E

Identifiers and Leadership

ISIN INE07BK01011

Hemadri Cements Balance Sheet Screener

Screen HEMACEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹24 against total liabilities of ₹24, down from ₹48 in 2024.

Latest statistics put total assets at ₹24 and shareholder funds at ₹-4, with a leverage ratio of 0.40.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 24 48 56 72 67 64 66 63 62 62
Current Assets 11 26 27 40 34 25 26 30 30 31
Fixed Assets 11 12 14 15 17 19 10 11 11 8

Liabilities

Total Liabilities 24 48 56 72 67 64 66 63 62 62
Current Liabilities 21 2 2 2 2 0 0 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity -4 23 34 50 49 48 48 47 46 45
Share Capital 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus -11 16 28 43 42 41 41 40 40 39

Hemadri Cements Income Statement Screener - Profit & Revenue Analysis

Screen Hemadri Cements income statement and profit fundamentals. Analyze HEMACEM quarterly results. Hemadri Cements reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹1 and net profit was ₹-19, equal to earnings per unit of ₹-27.80.

In that period expenses were ₹11, interest cost ₹2 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹8 and net profit of ₹-21.

Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 1 8 57 71 84 96 71 80 83 86 93 85
Expenses 11 27 66 88 81 90 68 77 81 78 81 74

Operating Costs and Margins

EBITDA -10 -19 -10 -18 3 6 2 3 2 9 12 11
Operating Profit % 0.00% -243.00% -19.00% -29.00% 1.00% 6.00% 3.00% -3.00% 2.00% 9.00% 12.00% 12.00%
Depreciation 2 2 2 2 2 2 1 1 1 1 1 1
Interest 2 1 1 1 0 0 1 1 0 0 0 0

Profit and Earnings

Profit Before Tax -13 -21 -13 -21 0 4 0 1 1 8 11 10
Tax 0 0 -2 -5 0 3 0 0 0 7 4 3
Net Profit -19 -21 -11 -15 0 1 0 1 1 1 7 7
EPS -27.80 -40.57 -16.39 -22.93 0.64 1.82 0.20 1.54 0.73 1.63 9.75 10.21

Hemadri Cements Cash Flow Screener - Liquidity Fundamentals

Screen HEMACEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2024-March, operating activities generated ₹2.

Over the same period, investing activities provided ₹0 and financing activities used ₹2.

Item 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Cash from Operations and Investing

Operating Activities 2 -11 -5 12 2 -4 -1 6 1 2
Investing Activities 0 0 -1 0 0 -9 0 -3 -1 0

Financing and Net Cash

Financing Activities -2 6 5 -6 -2 6 0 0 0 0
Net Cash Flow 0 -6 -1 6 0 -7 -1 3 0 2

Hemadri Cements Shareholding Pattern Screener

See Hemadri Cements shareholding pattern with promoter, FII, and DII holdings. Check Hemadri Cements promoter holding and ownership changes for HEMACEM on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 66.31%, foreign institutions 0.00%, domestic institutions 0.01% and the public 31.35%, spread across 8,141 shareholders.

The shareholder count was 8,141 in 2025-Mar, compared with 8,017 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar

Promoter Holding

Promoter Holding 66.31% 66.31% 66.31% 66.31% 66.31% 66.31% 66.31% 66.31%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 31.35% 31.33% 31.28% 31.32% 31.32% 31.34% 31.35% 31.87%
Other Holding 2.32% 2.35% 2.40% 2.36% 2.35% 2.34% 2.33% 1.81%
Shareholder Count 8,141 8,017 8,038 8,418 8,497 8,059 8,172 3,582

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Hemadri Cements. Hemadri Cements dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Hemadri Cements.

Hemadri Cements Stock Index Membership - Nifty & Sensex

See which indices include Hemadri Cements stock. Check HEMACEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Hemadri Cements is not part of any tracked indices.
Only major market indices are tracked in our system.

Hemadri Cements Market Events Screener - Corporate Actions

Get Hemadri Cements corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Hemadri Cements stock events that may affect HEMACEM share price, along with derivatives, futures and options activity and sector gainers.

7 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2025, with a record date of November 14, 2025.

It is followed by Quarterly Result Announcement dated August 13, 2025 and Annual General Meeting dated July 14, 2025.

Announcement Date Record Date Event Type Information Price Impact
2025-11-14 2025-11-14 Quarterly Result Announcement NA -3.05%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -9.68%
2025-07-14 2025-07-14 Annual General Meeting NA -6.94%
2025-05-03 2025-05-03 Quarterly Result Announcement NA 3.39%
2025-02-06 2025-02-06 Quarterly Result Announcement NA 4.32%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.12%
2024-07-31 2024-07-31 Annual General Meeting NA -1.43%

Hemadri Cements Competitors Screener - Peer Stocks Comparison

Screen HEMACEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Construction sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
UltraTech Cement 343,743 47.47 76,699 7.23% 6,040 40.24
Grasim Industries 184,965 20.84 149,937 13.38% 7,756 39.52
Ambuja Cements 134,962 19.02 37,699 9.83% 5,158 37.70
Shree Cement 95,470 55.47 19,872 -5.48% 1,124 23.87
JK Cement 42,741 42.04 12,052 3.00% 872 36.98
Dalmia Bharat 37,905 33.14 14,233 -5.15% 699 30.80
ACC 34,271 10.41 22,835 11.65% 2,402 43.69
Ramco Cements 24,029 63.74 8,560 -9.09% 268 48.06
Nuvoco Vistas Corporation 12,792 47.17 10,376 -3.63% 22 27.39
India Cements 12,331 994.76 4,357 -13.82% -124 55.21

Hemadri Cements Company Announcements - News & Reports Screener

Screen HEMACEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 28, 2026.

The next most recent announcements are dated September 27, 2026 and September 27, 2026.

Date Update Actions
2026-09-28 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-27 Unaudited Financial Results For Quarter Ended September 30 2025 Along With Limited Review Report. -
2026-09-27 Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2025 -
2025-11-06 Board Meeting Intimation for To Approve Quarterly Results For The Quarter Ended 309.2025 -
2025-10-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-27 Closure of Trading Window -
2025-09-11 Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Outcome Of Board Meeting Held On 11.09.2025 -
2025-09-02 Announcement under Regulation 30 (LODR)-Change in Management -
2025-09-02 Announcement under Regulation 30 (LODR)-Change in Management -
2025-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-08-13 Unaudited Financial Results For Quarter Ended June 30 2025 Along With Limited Review Report -
2025-08-13 Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 13.08.2025 -
2025-08-08 Board Meeting Intimation for Board Meeting Intimation For Consideration Of Un-Audited Results For The Quarter Ended 30.06.2025 -
2025-07-23 Commencement Of Voluntary Liquidation Proceedings Under The Provisions Of The Insolvency And Bankruptcy Code 2016. -
2025-07-15 Announcement under Regulation 30 (LODR)-Change in Management -
2025-07-15 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-07-15 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-07-11 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-06-27 Closure of Trading Window -
2025-06-20 Reg. 34 (1) Annual Report. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹50.88, within a 52-week range of ₹49.15 to ₹55.85. The P/E ratio is -1.79 and the P/B ratio is -3.90, with earnings per unit of ₹-40.57. Market capitalisation stands at ₹33.10 Cr. The company operates in the Construction sector, in the Cement industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.